Kurt Krejcy

Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study

Tudor–Eliade Ciuleanu, Thomas Brodowicz, Christoph Zielinski et al. · The Lancet · 2009 · 1.1K citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study

Heinz Gisslinger, Christoph Klade, Pencho Georgiev et al. · The Lancet Haematology · 2020 · 347 citations

Pharmacy, Hematology, Pharmacotherapy +5

Front-line treatment of advanced non-small-cell lung cancer with MTA (LY231514, Pemetrexed disodium, ALIMTA™ and cisplatin: A multicenter phase II trial

C. Manegold, U. Gatzemeier, Joachim von Pawel et al. · Annals of Oncology · 2000 · 155 citations

Medicine, Oncology, Pharmacology +10

Non‐Motor Symptoms in Parkinson's Disease are Reduced by Nabilone

Marina Peball, Florian Krismer, Hans‐Günther Knaus et al. · Annals of Neurology · 2020 · 119 citations · Full text

Medicine, Neurology, Pharmacology +16

Sex differences in concentrations of exhaled nitric oxide and plasma nitrate

Bernd Jilma, Johannes Kästner, Christa Mensik et al. · Life Sciences · 1996 · 113 citations

Education, Endocrinology, Air Pollution +4